Novavax, Inc.

Grantee website Gaithersburg, Maryland, United States
Purpose
to evaluate the safety, immunogenicity, and potential efficacy of a candidate vaccine to prevent COVID-19 infection and/or disease in the South African population
Division
Global Health
Date
JULY 2020
Region served
GLOBAL,
AFRICA
Committed amount
$15,000,000
Grant topic
HIV,
Pneumonia
Duration (months)
22
Grantee location
Gaithersburg, Maryland, United States

More about the foundation

Perspectives on the global pandemic response
The world has seen unprecedented challenges in the past months—as well as unprecedented collaboration.
Gates Foundation COVID-19 Response FAQ
Answers to frequently asked questions about the foundation’s COVID-19 response.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.